
28 October 2026
New Phase 3 trial results for a personalised mRNA treatment for people with high-risk…
Cancer52 represents the voice of rare and less common cancers*. They are an alliance of over 100 patient charities (including Melanoma UK) united in their vision of a better future for everyone affected by rare and less common cancers.








